Physician profile
Jaden D Evans
NPI 1881075018
$884.05
in general payments reported to CMS, 2019-2025
14 companies · $481 in 2025
The $481 reported for 2025 was more than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.35 · 2021: $130 · 2022: $78.35 · 2023: $28.21 · 2024: $154 · 2025: $481.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $664.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $663.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iba Proton Therapy, INC. | $252.03 | 2025 | |
| Boston Scientific Corporation | $195.44 | 2021-2025 | Spaceoar Vue System - 10ml |
| Progenics Pharmaceuticals, INC. | $70.83 | 2024-2025 | |
| Sumitomo Pharma America, INC. | $69.17 | 2023-2025 | Orgovyx |
| Pfizer INC. | $53.04 | 2022-2025 | |
| Novocure INC. | $51.24 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $40.19 | 2021-2022 | |
| Myovant Sciences INC. | $32.55 | 2021-2022 | |
| Dendreon Pharmaceuticals LLC | $29.19 | 2025 | Provenge |
| Bioprotect Medical, INC. | $28.72 | 2024 | Bioprotect Balloon Implant System |
| Tactile Systems Technology INC | $19.31 | 2025 | Nimbl, Flexitouch Plus |
| Tersera Therapeutics LLC | $17.39 | 2021 | |
| Myriad Genetic Laboratories, INC. | $12.60 | 2021 | |
| Blue Earth Diagnostics | $12.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaden Evans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.